Citation Impact
Citing Papers
Excitatory amino acid antagonists for acute stroke
2003
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Inadequate Antimicrobial Treatment of Infections
1999 Standout
Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: casecontrol study
2006
Prognosis and Outcomes of Patients With Community-Acquired Pneumonia
1996
Glutamate receptor ion channels
2005 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Chronic Thromboembolic Pulmonary Hypertension
2013
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
An emergency department–based randomized trial of nonbronchoscopic bronchoalveolar lavage for early pathogen identification in severe community-acquired pneumonia
2001
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
1997 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia
2005
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
2000 Standout
WHY DO NEUROPROTECTIVE DRUGS WORK IN ANIMALS BUT NOT HUMANS?
2000
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
2003 Standout
Describing reporting guidelines for health research: a systematic review
2011
Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis
1998
The Impact of Blood Cultures on Antibiotic Therapy in Pneumococcal Pneumonia
1999
Antithrombotic Therapy for VTE Disease
2012 Standout
1,026 Experimental treatments in acute stroke
2006 Standout
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Infections in Patients with Diabetes Mellitus
1999 Standout
Review: Cerebral microvascular pathology in ageing and neurodegeneration
2010
Neuroprotection in cardiac surgery
2003
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Effects of repeated doses and continuous infusions of the growth hormone-releasing peptide hexarelin in conscious male rats
1998
Induced hypothermia in critical care medicine: A review
2003
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*
2006 Standout
Pneumonia Mortality Reduction and Quality Improvement in a Community Hospital
1993
International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion
2005 Standout
Diagnostic and Prognostic Value of Interleukin-6 and C-reactive Protein in Community-acquired Pneumonia
1995
The Rewarming Rate and Increased Peak Temperature Alter Neurocognitive Outcome After Cardiac Surgery
2002
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review
2014
The Pathobiology of Vascular Dementia
2013 Standout
The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures
2001
Assessment of the Usefulness of Sputum Culture for Diagnosis of Community-Acquired Pneumonia Using the PORT Predictive Scoring System
2004
De-escalation therapy in ventilator-associated pneumonia*
2004
Applying Sputum as a Diagnostic Tool in Pneumonia
2002
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
The Contribution of Blood Cultures to the Clinical Management of Adult Patients Admitted to the Hospital With Community-Acquired Pneumonia
2003
Chronic thromboembolic pulmonary hypertension
2014
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease
2014
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Ventilator-associated Pneumonia
2002 Standout
The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia
1997
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Predicting Bacteremia in Patients with Community-Acquired Pneumonia
2003
Initial Microbiologic Studies Did Not Affect Outcome in Adults Hospitalized with Community-Acquired Pneumonia
1999
Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial Therapy
1993
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
2003 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
2000
Guidelines for the Primary Prevention of Stroke
2014 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Legionella and Legionnaires' Disease: 25 Years of Investigation
2002 Standout
Toward Wisdom From Failure
2002
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Methodology of neuropsychological research in multicentre randomized clinical trials: a model derived from The International Subarachnoid Aneurysm Trial
2004
The Rewarming Rate and Increased Peak Temperature Alter Neurocognitive Outcome After Cardiac Surgery
2002
Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis.
1996
Exame do escarro no manejo clínico dos pacientes com pneumonia adquirida na comunidade
2008
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
In Vivo Therapeutic Gas Delivery for Neuroprotection With Echogenic Liposomes
2010
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of Joseph E. Arrowsmith being referenced
Consensus Statement: Defining Minimal Criteria for Reporting the Systemic Inflammatory Response to Cardiopulmonary Bypass
2005
Central nervous system complications of cardiac surgery
2000
Cognitive change 5 years after coronary artery bypass surgery.
2003
The value of routine microbial investigation in community-acquired pneumonia
1991
Neurologic risk assessment, monitoring and outcome in cardiac surgery
1999
Successful Extracorporeal Membrane Oxygenation Support After Pulmonary Thromboendarterectomy
2008
Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial
2011
Surgery depresses pulsatile growth hormone release in rats for up to 2 days
1985
Consensus Statement: Minimal Criteria for Reporting the Systemic Inflammatory Response to Cardiopulmonary Bypass
2010
Neuroprotection of the Brain During Cardiopulmonary Bypass
1998